HyMedPoly – Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications
HyMedPoly aims to develop new therapies based on biomedical drug-free antibacterial polymers and inorganic materials for drug-free antibacterial hybrid biopolymers for infections.
Infection has become one of the toughest problems in the medical world, and as bacteria become more resistant to drugs there are fewer effective antibiotics to fight against pathogens.
A group of 9 universities and companies from across Europe is training a cohort of 15 Early Stage Researchers (ESRs) in the development of drug-free antibacterial materials for medical applications, such as wound care, implants and bio film prevention. The ESRs PhD projects are developing, synthesising and testing new biopolymers, bioceramics and bioactive glasses that can act as active agents to prevent or eradicate bacterial infections.
Each ESR is receiving practical training through state-of-the-art research projects at both world class academic institutes and companies and is addressing fundamental issues key to future new therapies through antibacterial biomaterials. The project is part of the European Commission’s initiative to develop European Industrial Doctorates with equal exposure to academia and industry, allowing them to combine research knowledge with business acumen.